{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:15:45Z","timestamp":1785507345507,"version":"3.56.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,31]]},"DOI":"10.7759\/cureus.113727","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T13:41:20Z","timestamp":1785505280000},"source":"Crossref","is-referenced-by-count":0,"title":["Vitiligo as a Potential Overlooked Comorbidity in Schizophrenia: Insights From Two Case Reports"],"prefix":"10.7759","author":[{"given":"Amina","family":"Abdelhamid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Amine","family":"Ennaciri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siham  B","family":"Belbachir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/psychiatry.IndianJPsychiatry_156_18","article-title":"A perspective study of cutaneous manifestations in primary psychiatric disorders in a tertiary care hospital","volume":"60","author":"George A","year":"2018","unstructured":"George A, Girisha BS, Rao S. A perspective study of cutaneous manifestations in primary psychiatric disorders in a tertiary care hospital. Indian J Psychiatry. 2018, 60:213-6. 10.4103\/psychiatry.IndianJPsychiatry_156_18","journal-title":"Indian J Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00131","article-title":"Autoimmune diseases and psychotic disorders","volume":"10","author":"Jeppesen R","year":"2019","unstructured":"Jeppesen R, Benros ME. Autoimmune diseases and psychotic disorders. Front Psychiatry. 2019, 10:131. 10.3389\/fpsyt.2019.00131","journal-title":"Front Psychiatry"},{"key":"ref3","article-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR)","author":"American Psychiatric Association","year":"2022","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). American Psychiatric Association, Washington, DC; 2022."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000508868","article-title":"A review of skin disease in schizophrenia","volume":"237","author":"McPhie ML","year":"2021","unstructured":"McPhie ML, Bridgman AC, Kirchhof MG. A review of skin disease in schizophrenia. Dermatology. 2021, 237:248-61. 10.1159\/000508868","journal-title":"Dermatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15255","article-title":"Association of vitiligo with hospitalization for mental health disorders in US adults","volume":"33","author":"Patel KR","year":"2019","unstructured":"Patel KR, Singam V, Rastogi S, Lee HH, Silverberg NB, Silverberg JI. Association of vitiligo with hospitalization for mental health disorders in US adults. J Eur Acad Dermatol Venereol. 2019, 33:191-7. 10.1111\/jdv.15255","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2017.04.018","article-title":"Pattern and prevalence of psychiatric disorders among patients attending dermatology OPD","volume":"29","author":"Raikhy S","year":"2017","unstructured":"Raikhy S, Gautam S, Kanodia S. Pattern and prevalence of psychiatric disorders among patients attending dermatology OPD. Asian J Psychiatr. 2017, 29:85-8. 10.1016\/j.ajp.2017.04.018","journal-title":"Asian J Psychiatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-023-01001-2","article-title":"Comorbidity burden among patients with vitiligo in the United States: a large-scale retrospective claims database analysis","volume":"13","author":"Ezzedine K","year":"2023","unstructured":"Ezzedine K, Soliman AM, Li C, Camp HS, Pandya AG. Comorbidity burden among patients with vitiligo in the United States: a large-scale retrospective claims database analysis. Dermatol Ther (Heidelb). 2023, 13:2265-77. 10.1007\/s13555-023-01001-2","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.07.549","article-title":"50526 Association of vitiligo and mental health outcomes: a systematic review and meta-analysis","volume":"91","author":"Abdi P","year":"2024","unstructured":"Abdi P, Manzar D, Suntres E, Maibach HI. 50526 Association of vitiligo and mental health outcomes: a systematic review and meta-analysis. J Am Acad Dermatol. 2024, 91:136. 10.1016\/j.jaad.2024.07.549","journal-title":"J Am Acad Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2003.00749.x","article-title":"Psychoactive drugs and skin","volume":"17","author":"Hautmann G","year":"2003","unstructured":"Hautmann G, Lotti T. Psychoactive drugs and skin. J Eur Acad Dermatol Venereol. 2003, 17:383-93. 10.1046\/j.1468-3083.2003.00749.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40199-018-0206-4","article-title":"In vitro melanogenesis inhibition by fluphenazine and prochlorperazine in normal human melanocytes lightly pigmented","volume":"26","author":"Otr\u0119ba M","year":"2018","unstructured":"Otr\u0119ba M, Beberok A, Wrze\u015bniok D, Buszman E. In vitro melanogenesis inhibition by fluphenazine and prochlorperazine in normal human melanocytes lightly pigmented. Daru. 2018, 26:85-9. 10.1007\/s40199-018-0206-4","journal-title":"Daru"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2023.03.007","article-title":"The role of lipids in vitiligo and schizophrenia","volume":"41","author":"Stamu-O'Brien C","year":"2023","unstructured":"Stamu-O'Brien C, Kroumpouzos G. The role of lipids in vitiligo and schizophrenia. Clin Dermatol. 2023, 41:89-94. 10.1016\/j.clindermatol.2023.03.007","journal-title":"Clin Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/519215-vitiligo-as-a-potential-overlooked-comorbidity-in-schizophrenia-insights-from-two-case-reports","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T13:41:22Z","timestamp":1785505282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/519215-vitiligo-as-a-potential-overlooked-comorbidity-in-schizophrenia-insights-from-two-case-reports"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.113727","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}